Proqr Therapeutics N V (PRQR)

May 13, 2025

DAFNA Capital Management LLC Buys 661,979 Shares of ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 13, 2025

May 13, 2025

ProQR Therapeutics (PRQR) Price Target Lowered by Oppenheimer | - GuruFocus

May 13, 2025

May 13, 2025

Oppenheimer Adjusts ProQR Therapeutics N.V Price Target to $9 From $15, Maintains Outperform Rating - marketscreener.com

May 13, 2025

May 13, 2025

ProQR (PRQR) Price Target Cut by Oppenheimer Amid Clinical Updates | PRQR Stock News - GuruFocus

May 13, 2025

May 12, 2025

ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences - GlobeNewswire

May 12, 2025

May 12, 2025

Raymond James Financial Inc. Invests $260,000 in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

May 12, 2025

May 12, 2025

ProQR Therapeutics (NASDAQ:PRQR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

May 12, 2025

May 11, 2025

ProQR Therapeutics (NASDAQ:PRQR) Receives Average Recommendation of “Buy” from Analysts - Defense World

May 11, 2025

May 09, 2025

ProQR: Q1 Earnings Snapshot - News-Times

May 09, 2025

May 09, 2025

1,181,413 Shares in ProQR Therapeutics (NASDAQ:PRQR) Acquired by ArrowMark Colorado Holdings LLC - MarketBeat

May 09, 2025

May 09, 2025

New Forecasts: Here's What Analysts Think The Future Holds For ProQR Therapeutics N.V. (NASDAQ:PRQR) - simplywall.st

May 09, 2025

May 08, 2025

ProQR Therapeutics NV earnings missed, revenue topped estimates By Investing.com - Investing.com Nigeria

May 08, 2025

May 08, 2025

ProQR Therapeutics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025

May 08, 2025

ProQR Therapeutics NV earnings missed, revenue topped estimates - Investing.com

May 08, 2025

May 08, 2025

ProQR (PRQR) Reports Q1 Revenue Growth and Strategic Milestones - GuruFocus

May 08, 2025

May 08, 2025

ProQR Reports Q1 2025 Financial Results Amid Rising R&D Costs - TipRanks

May 08, 2025

May 08, 2025

ProQR Therapeutics Advances Axiomer RNA Editing Pipeline with Leadership Appointments and Strong Financial Position - Nasdaq

May 08, 2025

May 08, 2025

ProQR Announces First Quarter 2025 Operating and Financial Results - GlobeNewswire

May 08, 2025

May 07, 2025

ProQR Therapeutics (PRQR) Expected to Announce Earnings on Thursday - MarketBeat

May 07, 2025

May 06, 2025

Invesco Ltd. Purchases Shares of 11,887 ProQR Therapeutics (NASDAQ:PRQR) - Defense World

May 06, 2025

May 06, 2025

Analysts Issue Forecasts for PRQR FY2025 Earnings - MarketBeat

May 06, 2025

May 06, 2025

ProQR Therapeutics (NASDAQ:PRQR) Shares Acquired by Boothbay Fund Management LLC - MarketBeat

May 06, 2025

May 05, 2025

ProQR Therapeutics N.V (NASDAQ: PRQR) Posted 2.58% Gain This Year: What’s Next? - Stocksregister

May 05, 2025

May 05, 2025

JPMorgan Chase & Co. Has $142,000 Holdings in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

May 05, 2025

May 05, 2025

Evercore ISI Initiates Coverage on ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 05, 2025

May 04, 2025

ProQR Therapeutics (NASDAQ:PRQR) Now Covered by Analysts at Cantor Fitzgerald - MarketBeat

May 04, 2025

May 02, 2025

ProQR Therapeutics NV expected to post a loss of 9 cents a shareEarnings Preview - TradingView

May 02, 2025

May 02, 2025

ProQR Announces Webcast of Presentation at the 2025 Citizens Lif - GuruFocus

May 02, 2025

May 02, 2025

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference | PRQR Stock News - GuruFocus

May 02, 2025

May 02, 2025

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference - GlobeNewswire

May 02, 2025

May 02, 2025

RNA Editing Pioneer ProQR to Showcase Breakthrough Axiomer Platform at Major Healthcare Conference - Stock Titan

May 02, 2025

May 02, 2025

ProQR Therapeutics (NASDAQ:PRQR) Earns Outperform Rating from Analysts at Evercore ISI - Defense World

May 02, 2025

May 02, 2025

ProQR Therapeutics (NASDAQ:PRQR) Research Coverage Started at Cantor Fitzgerald - Defense World

May 02, 2025

May 01, 2025

Adage Capital Partners GP L.L.C. Purchases 5,976,813 Shares of ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 01, 2025

May 01, 2025

ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 - The Manila Times

May 01, 2025

Apr 30, 2025

ProQR Therapeutics N.V [PRQR] Investment Appeal on the Rise - knoxdaily.com

Apr 30, 2025

Apr 30, 2025

RNA Editing Market Deep Research 2025-2032 | QIAGEN N.V., ProQR - openPR.com

Apr 30, 2025

Apr 29, 2025

Evercore ISI Group Initiates Coverage of ProQR Therapeutics N.V. (PRQR) with Outperform Recommendation - Nasdaq

Apr 29, 2025

Apr 29, 2025

ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald - Yahoo Finance

Apr 29, 2025

Apr 29, 2025

ProQR Therapeutics initiated with an Outperform at Evercore ISI - Yahoo Finance

Apr 29, 2025

Apr 29, 2025

XTX Topco Ltd Takes $163,000 Position in ProQR Therapeutics (NASDAQ:PRQR) - The AM Reporter

Apr 29, 2025

Apr 29, 2025

Riding the Waves: A Guide to Investing in PRQR Stock - investchronicle.com

Apr 29, 2025

Apr 29, 2025

Evercore ISI sets ProQR stock Outperform with $5 target By Investing.com - Investing.com India

Apr 29, 2025

Apr 29, 2025

ProQR Therapeutics (PRQR) Receives Overweight Rating and $8 Pric - GuruFocus

Apr 29, 2025